# Nuclide record ge-healthcare (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/ge-healthcare/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "ge-healthcare" ;
  schema:name "GE HealthCare"@en ;
  schema:description "GE HealthCare, of Chicago, makes PET/CT, MRI and CT scanners (Omni Legend, SIGNA, Revolution) and PET tracers through its Pharmaceutical Diagnostics business, including Cerianna, the fluoroestradiol F-18 agent that images oestrogen receptors in breast cancer. Whether receptor-imaging tracers change treatment decisions often enough to be reimbursed is its tracer business's open question."@en ;
  schema:url <https://nuclide.cc/companies/ge-healthcare/>, <https://www.gehealthcare.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/GE_HealthCare> ;
  owl:sameAs <http://www.wikidata.org/entity/Q1152374> ;
  schema:citation <https://www.gehealthcare.com> ;
  schema:addressCountry "US" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet-ct/>, <https://nuclide.cc/technologies/ct/> ;
  nuclide:trials <https://nuclide.cc/trials/nct07219238/> .